Table 1 General characteristics of patients (nā=ā46)
From: Expression and potential role of SNF5 in endometrial carcinoma
Characteristics | No. (%) of patients |
|---|---|
Age, years | |
āMean [range] | 59.5 [39ā80] |
Menopausal status | |
āPostmenopausal | 38 (82.6) |
āPremenopausal | 6 (13.0) |
āUnknown | 2 (4.3) |
Histology | |
āEndometrioid | 40 (87.0) |
āNon-endometrioid | 6 (13.0) |
FIGO stage | |
āI | 31 (67.4) |
āII | 8 (17.4) |
āIII | 7 (15.2) |
Histological grade | |
āG1 | 18 (39.1) |
āG2 and G3 | 28 (60.9) |
Myometrial invasion | |
āāā„ā1/2 | 15 (32.6) |
āā<ā1/2 | 31 (67.4) |
Lymphatic metastasis | |
āYes | 7 (15.2) |
āNo | 39 (84.8) |